Circulating miR-583 and miR-663 Refer to ZHENG differentiation in chronic hepatitis B

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Zhang, Hui ^a   Guan, Yan ^a   Lu, Yi Yu ^a   Hu, Yi Yang ^a   Huang, Shuang ^b   Su, Shi Bing ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 583; MICRORNA 663; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; LIVER DISEASE; LIVER GALLBLADDER DAMPNESS HEAT SYNDROME; LIVER KIDNEY YIN DEFICIENCY SYNDROME; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NERVE FIBER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 84876538258     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/751341     Document Type: Article

References (32)

1. Su S. B., Lu A., Li S., Jia W., Evidence-based ZHENG: a traditional Chinese medicine syndrome. Evidence-Based Complementary and Alternative Medicine 2012 2012 2 10.1155/2012/246538 246538
2. Tang J. L., Liu B. Y., Ma K. W., Traditional Chinese medicine. The Lancet 2008 372 9654 1938 1940
3. Lu A., Jiang M., Zhang C., Chan K., An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis. Journal of Ethnopharmacology 2012 141 2 549 556 10.1016/j.jep.2011.08.045
4. Ambros V., The functions of animal microRNAs. Nature 2004 431 7006 350 355 10.1038/nature02871 (Pubitemid 39265675)
5. Kloosterman W. P., Plasterk R. H. A., The diverse functions of microRNAs in animal development and disease. Developmental Cell 2006 11 4 441 450 2-s2.0-33748928159 10.1016/j.devcel.2006.09.009 (Pubitemid 44430905)
6. El-Hefnawy T., Raja S., Kelly L., Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clinical Chemistry 2004 50 3 564 573 10.1373/clinchem.2003.028506 (Pubitemid 38297307)
7. Zernecke A., Bidzhekov K., Noels H., Shagdarsuren E., Gan L., Denecke B., Hristov M., Köppel T., Jahantigh M. N., Lutgens E., Wang S., Olson E. N., Schober A., Weber C., Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science Signaling 2009 2 100 ra81 2-s2.0-77449127999 10.1126/scisignal.2000610
8. Hunter M. P., Ismail N., Zhang X., Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008 3 11 e3694
9. Valadi H., Ekström K., Bossios A., Sjöstrand M., Lee J. J., Lötvall J. O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 2007 9 6 654 659 2-s2.0-34249302620 10.1038/ncb1596 (Pubitemid 47214727)
10. Mitchell P. S., Parkin R. K., Kroh E. M., Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 2008 105 30 10513 10518 10.1073/pnas.0804549105
11. Zhang H., Li Q. Y., Guo Z. Z., Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B. World Journal of Gastroenterology 2012 18 37 5188 5196
12. Laterza O. F., Lim L., Garrett-Engele P. W., Vlasakova K., Muniappa N., Tanaka W. K., Johnson J. M., Sina J. F., Fare T. L., Sistare F. D., Glaab W. E., Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clinical Chemistry 2009 55 11 1977 1983 10.1373/clinchem.2009.131797
13. Gilad S., Meiri E., Yogev Y., Serum microRNAs are promising novel biomarkers. PLoS One 2008 3 9 e3148
14. Liu N. K., Wang X. F., Lu Q. B., Xu X. M., Altered microRNA expression following traumatic spinal cord injury. Experimental Neurology 2009 219 2 424 429 10.1016/j.expneurol.2009.06.015
15. Wang G. K., Zhu J. Q., Zhang J. T., Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. European Heart Journal 2010 31 6 659 666 10.1093/eurheartj/ehq013
16. Wang J. F., Yu M. L., Yu G., Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochemical and Biophysical Research Communications 2010 394 1 184 188 10.1016/j.bbrc.2010.02.145
17. Cheng Y., Tan N., Yang J., Liu X., Cao X., He P., Dong X., Qin S., Zhang C., A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clinical Science 2010 119 2 87 95 2-s2.0-77954932535 10.1042/CS20090645
18. Chen X., Ba Y., Ma L., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research 2008 18 10 997 1006 10.1038/cr.2008.282
19. Gui J., Tian Y., Wen X., Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clinical Science 2011 120 5 183 193 10.1042/CS20100297
20. Chim S. S., Shing T. K., Hung E. C., Detection and characterization of placental microRNAs in maternal plasma. Clinical Chemistry 2008 54 3 482 490 10.1373/clinchem.2007.097972 (Pubitemid 351348154)
21. Hepatitis B Surveillance and control. World Health Organization, October 2009, http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index4.html
22. Custer B., Sullivan S. D., Hazlet T. K., Iloeje U., Veenstra D. L., Kowdley K. V., Global epidemiology of hepatitis B virus. Journal of Clinical Gastroenterology 2004 38 10, supplement 3 S158 S168 2-s2.0-20944445480
23. Tiollais P., Pourcel C., Dejean A., The hepatitis B virus. Nature 1985 317 6037 489 495 2-s2.0-0022341264 (Pubitemid 16224154)
24. Wang S. L., Yao N. L., Lv W. L., Advances in studies on effect superiorities of traditional Chinese medicine on chronic hepatitis B. China Journal of Chinese Materia Medica 2007 32 23 2468 2470 2-s2.0-38549135493
25. Tang L. L., Sheng J. F., Xu C. H., Liu K. Z., Clinical and experimental effectiveness of Astragali compound in the treatment of chronic viral hepatitis B. Journal of International Medical Research 2009 37 3 662 667 2-s2.0-70349246547
26. Wang B. E., Treatment of chronic liver diseases with traditional Chinese medicine. Journal of Gastroenterology and Hepatology 2000 15 supplement E67 E70 2-s2.0-0033944607 10.1046/j.1440-1746.2000.02100.x (Pubitemid 30435739)
27. Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Guide to Prevention and Treatment of Chronic Hepatitis B 2005
28. The Standards of TCM Differential Syndromes of Viral Hepatitis. Internal Medicine Hepatopathy Committee of Chinese Traditional Medicine Association, December 1991
29. González-Terán B., Cortés J. R., Manieri E., Eukaryotic elongation factor 2 controls TNF- α translation in LPS-induced hepatitis. The Journal of Clinical Investigation 2013 123 1 164 178 10.1172/JCI65124 65124
30. Cassiman D., Denef C., Desmet V. J., Roskams T., Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology 2001 33 1 148 158 2-s2.0-0035200716 10.1053/jhep.2001.20793 (Pubitemid 32016897)
31. Cao S., Yaqoob U., Das A., Shergill U., Jagavelu K., Huebert R. C., Routray C., Abdelmoneim S., Vasdev M., Leof E., Charlton M., Watts R. J., Mukhopadhyay D., Shah V. H., Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF- β signaling in hepatic stellate cells. Journal of Clinical Investigation 2010 120 7 2379 2394 2-s2.0-77954976056 10.1172/JCI41203
32. Guégan J. P., Frémin C., Baffet G., The MAPK MEK1/2-ERK1/2 pathway and its implication in hepatocyte cell cycle control. International Journal of Hepatology 2012 2012 13 10.1155/2012/328372 328372